Impact of regulatory reform on clearing and settling OTC derivatives

London
8 & 9 September 2010

New York
15 & 16 September 2010

***** DO NOT ENTER ANYTHING HERE OR REMOVE THIS BLOCK. THIS IS A HACK TO USE STYLESHEET TO CONTROL THE LAYOUT ****

Learning outcomes:

By the end of the course you will have a clearer understanding of the emerging regulatory framework proposed to govern the OTC derivatives market. You will also gain technical knowledge of the specific processes and institutions involved in the centralised clearing and settlement lifecycle.

Specifically you will find out about:

  • Global regulatory reforms and their impact on clearing and settlement
  • How trade repositories increase transparency
  • The role of CCP's in clearing and settlement
  • Product eligibility for central clearing
  • Valuing OTC derivatives
  • Managing collateral in centralised and bilateral trades
  • Regulatory impact on the cost of clearing and settlement

Course dates & venues

LONDON 8 & 9 September 2010

VENUE DETAILS

arrowBOOK NOW

NEW YORK 15 & 16 September 2010

VENUE DETAILS

BOOK NOW

Course tutors

LONDON

Anthony Kirby
Director, Regulatory and Risk Management, Ernst & Young LLP

Rory Cunningham
Chairman, EUROPEAN ASSOCIATION OF CLEARING HOUSES AND DIRECTOR AT LCH CLEARNET

John Wilson
Global Head of OTC Clearing, ROYAL BANK OF SCOTLAND

Anthony Belchambers
Chief Executive Officer, FUTURES AND OPTIONS ASSOCIATIONS

Andy Green
Vice President, DTCC

Steve Ingle
Derivatives Product Manager, BNY MELLON

Raymond Kahn
Head of OTC Client Clearing, BARCLAYS CAPITAL

Mike Stonier
Vice President, European Collatral Operations, J.P. MORGAN

Tracey Pritchard
Vice President, European Collateral Operations, J.P. MORGAN

NEW YORK

Wendy Ng
Assistant Vice President, Financial Infrastructure, FEDERAL RESERVE BANK OF NEW YORK

Kimberly Taylor
Managing Director and President, CME CLEARING HOUSE

Ronald Filler
Lecturer, NEW YORK LAW SCHOOL

Marisol Collazo
Vice President, DTCC

David Olsen
Global Head of OTC Clearing, JP MORGAN

Christopher Coleman
Vice President, BNY MELLON

Raymond Kahn
Head of OTC Client Clearing, BARCLAYS CAPITAL

Jason Swankoski
Executive Director, MORGAN STANLEY

Christian Ferrer
Vice President, Global Commodities, BANK OF AMERICA MERRILL LYNCH

Course highlights:

  • Examining exemptions from OTC derivative regulatory reform
  • How a CCP mitigates counterparty credit risk
  • The settlement services provided by trade repositories
  • Process of valuing different OTC derivative asset classes
  • Impact of increased capital charges on bilateral OTC derivatives trades
  • The management of collateral in clearing and settlement